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Accepted 22 May 2016Background: Transcranial surgery is consideredmore appropriate than an endonasal endoscopic approach (EEA)
for a large cavernous sinus meningioma with lateral extension.
Case presentation:A 6-cm-diameter hypervascular meningioma around cavernous sinus invaded the orbital apex
and infratemporal fossa. 80% of the tumor was removed without too much blood loss via endoscopic endonasal
transpterygoidal-infratemporal approach. Preoperative embolization from some feeding arteries was done, and
80% of the tumor staining disappeared.
Discussion: Tumor removal rates for giant meningioma are worse with EEA than with the transcranial approach
because of various anatomical limitations and blood control. Recently, EEA has become more widely used with
approaches such as the transpterygoidal approach. The operation can be done safely with preoperative emboli-
zation because the operative view is clear without bleeding.
Conclusion: Preoperative embolization for a large hypervascular tumormakes EEAmore effective. A giantmenin-
gioma can be removed by EEA if the anatomical limitations can be identiﬁed and approached safely and
effectively.
© 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
Endonasal endoscopic approach
Cavernous sinus meningioma
Middle cranial fossa
Preoperative embolization1. Introduction
The endoscopic endonasal approach (EEA) has advantages, such as
the favorable cosmetic results, the avoidance of brain retraction, and
early bilateral optic nerve decompression. The rate of postoperative ce-
rebrospinal ﬂuid (CSF) leaks has been improved with the use of
vascularized pedicled ﬂaps [1]. Recently, EEA has been considered suit-
able for midline tumors. Today, we can approach a broad area of the
skull base by EEA, and the indications for EEA have gradually increased.
For example, cavernous sinusmeningioma is not usually treated by cra-
niotomy because of its associated neurological complications. On the
other hand, it can sometimes be treated by EEA. Generally, a large me-
ningioma is considered appropriate for open surgery because it is difﬁ-
cult to accurately devascularize feeding arteries by the endoscopic
approach. However, preoperative embolization can overcome that
weakness [2].
In the present case, a giantmeningioma located in themiddle cranial
fossa was removed after preoperative embolization. The limitations of
EEA and the advantages of preoperative embolization are reviewed.mura).
. This is an open access article under2. Case report
2.1. Onset
A 66-year-old Asian woman was referred to our hospital with right
visual acuity disturbance. A giant meningioma around the cavernous
sinuswas found and removed via craniotomy24 years earlier. A diagno-
sis of meningothelial meningioma was made. After the operation,
gamma knife radiation was applied to the remaining tumor. Magnetic
resonance imaging (MRI) showed tumor regrowth 24 years after the
ﬁrst operation. Her right eye was already blind, and she had a sensory
disturbance of the middle and lower face, implying V2 and V3
involvement.
2.2. Preoperative radiological and angiographic ﬁndings
MRI showed the right remaining solid parasellar tumor, 6 cm in di-
ameter, that invaded the orbital apex, sphenoid sinus, maxillary sinus,
and infratemporal fossa (Fig. 1A,B). Gadolinium (Gd)-enhanced MRI
showed strong enhancement. Angiography showed the feeding arteries
mainly from the right middle meningeal artery (MMA), accessory men-
ingeal artery (AMA), sphenopalatine artery (SPA), and ascending pha-
ryngeal artery (APA) (Fig. 1C). Right internal carotid artery wasthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. A) Preoperative Gd-enhanced axial MRI shows the remaining right solid parasellar tumor of 6 cm in diameter invading the orbital apex, sphenoid sinus, maxillary sinus, and nasal
cavity. B) Preoperative Gd-enhanced coronal MRI shows tumor invasion to the infratemporal fossa. C) Angiography shows the feeding arteries from the right middle meningeal artery,
accessory meningeal artery, ascending pharyngeal artery, and internal maxillary artery. D,E) Postoperative Gd-enhanced axial MRI shows a small amount of residual tumor located
outside the right orbit and infratemporal fossa. F) Tumor stain has mostly disappeared after coil and embosphere embolization.
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external and internal carotid artery. It was thought to be difﬁcult to co-
agulate all of the feeding arteries during EEA. Therefore, preoperative
embolization was performed on the day before the operation. The
right MMA, AMA, the pharyngeal branch of the APA, and the SPA were
embolized using a coil and Embosphere (®Microspheres, 300–
500 μm), and 80% of tumor staining disappeared (Fig. 1F).
2.3. Operation
Tumor removal was done via an endoscopic endonasal
transpterygoidal-infratemporal approach. Subtotal removal (80%) was
achieved. Preoperative embolization of IMA was effective, thus only
minor bleeding was identiﬁed during tumor removal (Fig. 2A). MostFig. 2.A)The tumor is soft andgreyish. Bleeding from the tumor is controlledbecause the feedin
thin layer has remained. The sella turcica, bilateral orbit, clivus, and infratemporal fossa are ident
the sphenoid sinus.)of the tumor in the infratemporal fossa and middle cranial fossa and
around the orbit was removed, except for the lower site of the
infratemporal fossa and the lateral site of the orbit. During the opera-
tion, the infraorbital nerve and the maxillary nerve were identiﬁed.
The foramen rotundum could not be identiﬁed because of tumor inva-
sion. A small amount of tumor was deliberately left behind (Fig. 2E) be-
cause the patient had a past history of subarachnoid hemorrhage and a
ventriculoperitoneal shunt had been inserted earlier, and liquorrhea
had to be prevented. The C5 portion of the internal carotid artery and
the right abducens nerve were identiﬁed at the clivus, but both had al-
ready been cut at the previous operation. The navigation system identi-
ﬁed the cavity after tumor resection. The upper and lower parts of the
clivus, the left carotid canal, and the lateral side of the foramen
rotundum could be approached by EEA (Fig. 3A–D). Reconstruction ofg arterieswere embolized on theday before surgery. B)Most of the tumor is removed, but a
iﬁed. (blue dot:ﬂoor of the sella turcica, yellowdot: carotid prominence, green dot:ﬂoor of
Fig. 3. Navigation system shows the (A) left carotid canal, (B) the base of the right middle cranial fossa, and the foramen rotundum.
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Total blood loss was less than 300 ml without blood transfusion, and
surgical time was seven hours.
2.4. Postoperative course
CT performed one day postoperatively showed a small amount of re-
sidual tumor (Fig. 1D,E). The patient's postoperative course was un-
eventful. The patient was discharged from our hospital 13 days
postoperatively with no new neurological sequelae.
3. Discussion
Generally, transcranial surgery is considered more appropriate for
large cavernous sinus meningiomas with lateral extension, invasion to
the optic canal, and vascular encasement that needs delicate technique
[1,2]. However, recently, delicate procedures for neural and vascular
structures can be performed via EEA. Thus, the use of EEA has spread,
except for tumors larger than 4 cm and edematous tumors [1]. EEA is
better especially for midline tumors. In addition, the advantages of
EEA include a better cosmetic result, avoidance of brain retraction,
early devascularization including the anterior and posterior ethmoidal
arteries, and early bilateral optic nerve decompression [2]. However,
areas that can be approached by EEA are continuing to spread. For ex-
ample, there are approaches to reach the anterior, lateral and inferior
sites as described below. Some anatomical limitations of these ap-
proaches have been identiﬁed. The ﬂoor of the frontal sinus is the ante-
rior limitation of the transfrontal approach. The upper cervical spine is
the inferior limitations of the transodontoid approach. The
transpterygoidal approach can access the infratemporal fossa and the
lateral recess of the sphenoid sinus [3]. There are some limitationsmen-
tioned above, but tumor removal rates, visual outcomes, and endocrino-
logical outcomes are equivalent to those of the transcranial approach. In
addition, the rate of postoperative CSF leakage is decreased by using the
vascularized pedicled ﬂap for reconstruction of skull base defects [1–3].
Thus, EEA tends to overcome its weaknesses.
In this case, all anatomical limitations of EEA were identiﬁed during
surgery. If the tumor invades larger areas, a combined or staged ap-
proach is thought to be necessary.
It is often difﬁcult to control intraoperative bleeding formeningiomas.
Currently, preoperative embolization is often done for hypervascular tu-
mors. Preoperative embolization decreases blood loss, shortens surgical
time, and improves the rate of removal. Tumor removal can be done safe-
ly, because the operative view is clear without bleeding [4,5].
On the other hand, embolization of the feeding arteries from the ex-
ternal carotid artery for tumors thatmainly feed from the internal carot-
id artery may affect hemodynamic status, which increases the risk of
surgical removal. Embolization has some complications, such as skinand oralmucosal ulcers, trigeminal and facial nerve palsies, and trismus,
caused by internal maxillary artery occlusion [4,5].
Recently, craniotomyhas sometimes been combinedwith preopera-
tive embolization. However, no reports have discussed the advantages
of preoperative embolization for endoscopic tumor removal.
Certainly, EEA can devascularize the feeding arteries, such as the an-
terior and posterior ethmoidal arteries on the frontal cranial base. In ad-
dition, it can devascularize SPA outside of sphenopalatine foramen.
However, it is difﬁcult to devascularize numerous feeding arteries
from the lateral side such as APA and MMA and the pial supply from
the internal carotid artery at an early stage. Preoperative endovascular
procedure can make embolization of these arteries. EEA often needs in-
ternal decompression of the tumor. Therefore, intratumoral emboliza-
tion is important so that EEA can be done safely.
Thus, preoperative embolization ismore effective for EEA. If intraop-
erative bleeding is controlled by preoperative embolization, we can ap-
proach any anatomical limitations with a clear working view.
Hypervascular tumors larger than 4 cm can be removed safely by EEA
with preoperative embolization.
4. Conclusion
Preoperative embolization for hypervascular large tumors makes
EEA more effective. Tumors larger than 4 cm can be removed by EEA if
any anatomical limitations can be identiﬁed.
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